Surgical Outcomes After Conservative Resection of Vestibular Schwannoma in the Elderly
Autor: | Seilesh Babu, Alexander L. Luryi, John F. Kveton, Christopher A. Schutt, Dennis I. Bojrab |
---|---|
Rok vydání: | 2021 |
Předmět: |
Adult
medicine.medical_specialty Adolescent Psychological intervention Schwannoma Radiosurgery Resection Neurotology Young Adult Postoperative Complications Otology Diabetes mellitus Humans Medicine Stage (cooking) Aged Retrospective Studies Aged 80 and over Vestibular system business.industry Neuroma Acoustic Middle Aged medicine.disease Sensory Systems Surgery Facial Nerve Treatment Outcome Otorhinolaryngology Neurology (clinical) business |
Zdroj: | Otology & Neurotology. 42:e1358-e1361 |
ISSN: | 1537-4505 1531-7129 |
Popis: | Objective To assess outcomes after surgery for vestibular schwannoma in patients over 70 years of age. Study design Retrospective chart review. Setting Two tertiary otology and neurotology centers. Patients and interventions Patients undergoing primary surgery for vestibular schwannoma between 2007 and 2018. Main outcome measures Postoperative complications and surgical outcomes. Results A total of 452 patients met inclusion criteria, 31 of whom (6.9%) were over 70 years of age. Age ranged from 18 to 90 years with a mean of 53 years. Elderly patients were more likely to have pre-existing hypertension (58.1% versus 34.0%, p = 0.007) and diabetes mellitus (19.4% versus 7.4%, p = 0.02). Elderly patients were less likely to undergo gross total resections of their tumors (35.5% versus 60.6%, p = 0.05) although they were not statistically significantly more likely to undergo subtotal ( 0.05). Elderly patients were also less likely to undergo second stage procedures (0% versus 9.5%, p = 0.04). There were no significant differences between elderly and non-elderly patients in the rates of any complications, ultimate facial nerve function, or duration of surgery. No patients over 70 years of age expired within 1 year of surgery. Conclusions Conservative surgery for vestibular schwannoma in appropriately selected elderly patients is appropriate and safe, given adequate consideration to risk-benefit analysis and goals of care. |
Databáze: | OpenAIRE |
Externí odkaz: |